Breaking News, Financial News

Financial Report: Sanofi

Revenues up 16% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi 2Q Revenues: €9.4 billion (+16%) 2Q Earnings: €1.8 billion (+20%) YTD Revenues: €18.2 billion (+14%) YTD Earnings: €3.6 billion (+16%) Comments: Diabetes sales neared €2.0 billion in the quarter, up 11% driven by Lantus sales of €1.7 billion, up 10%. Genzyme sales were €907, up 41%. Plavix sales were €545 million, up 28%. Lovenox sales were €433 milion, up 3% Renagel/Renvela sales were up 69% to €231 million. Aprovel sales were €224 million, up 16%. Oncology sales were up 1...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters